The Apple CEO is set to collect about $120 million in stock tied to the company’s performance.
Cook was given a restricted stock award when he took over for Steve Jobs in 2011. On Friday, he will earn 560,000 shares of Apple (AAPL). It’s not clear whether he plans to cash out those shares.
About half of that award was contingent on Apple’s success: The stock needed to outperform two-thirds of the companies in the S&P 500 over the past three years.
Apple met that threshold. Its stock has been skyrocketing since August 2017 — up nearly 35% for the month. It’s climbed by 25% for the year.
Under Cook, Apple just became the first $1 trillion American company.
Friday’s payout is much bigger than last year’s, when Cook received $89 million. Bloomberg first reported news of the payment.
Cook has also said he plans to give away some of his fortune. On Tuesday he did just that, donating 23,000 shares — worth $5 million — to charity, according to a SEC filing.
Top Stocks To Invest In 2021: Lancaster Colony Corporation(LANC)
Lancaster Colony Corporation manufactures and markets specialty food products for the retail and foodservice markets in the United States. It offers salad dressings and sauces under the Marzetti, Cardinis, Simply Dressed, Katherines Kitchen, and Girards brand names; fruit glazes, vegetable dips, and fruit dips under the Marzetti brand name; Greek yogurt vegetable dips and hummus under the Otria brand name; and frozen garlic breads under the New York BRAND, Mamma Bella, and Mamma Bella’s brand names. The company also provides frozen Parkerhouse style yeast dinner rolls and sweet rolls, as well as biscuits under the Sister Schuberts, Marshalls, and Mary Bs brand names; premium dry egg noodles under the Inn Maid and Amish Kitchen brand names; frozen specialty noodles under the Reames and Aunt Vis brand names; croutons and related products under the New York BRAND, Texas Toast, Chatham Village, Cardinis, Simply Dressed, and Marzetti brand names; snack sticks under the New York BRAND name; flatbread wraps and pizza crusts under the Flatout brand name; and caviar under the Romanoff brand name. In addition, it manufactures and sells other products to brand license agreements, including Olive Gardens dressing, Jack Daniel’s mustards, Hungry Girl flatbreads, and Ortallis balsamic vinegar. The companys products are sold through sales personnel, food brokers, distributors, retailers, and restaurants, as well as industrial customers. Lancaster Colony Corporation was founded in 1961 and is based in Columbus, Ohio.
- [By Motley Fool Transcribing]
Lancaster Colony (NASDAQ:LANC) Q4 2018 Earnings Conference CallAug. 23, 2018 10:00 a.m. ET
Prepared Remarks Questions and Answers Call Participants
Top Stocks To Invest In 2021: First Bank(FRBA)
First Bank provides various banking products and services to individuals, businesses, and governmental entities in New Jersey and Pennsylvania. The company accepts various deposits, including non-interest bearing demand deposits, interest bearing demand accounts, money market accounts, savings accounts, and certificates of deposit, as well as commercial checking accounts. Its loan products include commercial and industrial loans; commercial real estate loans, such as commercial real estate owner-occupied and investor, construction and development, and multi-family real estate loans; residential real estate loans comprising residential mortgages, first and second lien home equity loans, and revolving lines of credit; and consumer loans, which consists of auto, personal, traditional installment, and other loans. The company also provides investment, Internet and mobile banking, electronic bill payment, banking by phone, ATM and debit cards, wire transfer, and automatic and ACH transfer services. As of February 17, 2016, it operated 10 full-service branches in Cranbury, Denville, Ewing, Flemington, Hamilton, Lawrence, Randolph, Somerset, and Williamstown, New Jersey; and Trevose, Pennsylvania. First Bank was founded in 2006 and is headquartered in Hamilton, New Jersey.
- [By Shane Hupp]
Media coverage about First Bank (NASDAQ:FRBA) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. First Bank earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave media coverage about the bank an impact score of 43.7118873805192 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
- [By Joseph Griffin]
First Bank (NASDAQ: FRBA) and Marlin Business Services (NASDAQ:MRLN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.
Top Stocks To Invest In 2021: Galapagos NV(GLPG)
Galapagos NV, a clinical stage biotech company, develops and commercializes novel medicines in Belgium, Croatia, France, and the Netherlands. The company is developing filgotinib, which has completed Phase 2 clinical trial for the treatment of rheumatoid arthritis and Crohns disease; GLPG1837, which is in Phase 2 clinical program, as well as GLPG2222, which is in Phase 1 clinical trial for treatment of cystic fibrosis mutations; and GLPG1690, which has completed Phase 1 clinical trial for the treatment of idiopathic pulmonary fibrosis. It is also developing GLPG1972, which is in Phase 1 clinical trial for the treatment of osteoarthritis; MOR106, which is in pre-clinical stage for the treatment of inflammatory diseases; and GLPG2665, a pre-clinical candidate for cystic fibrosis. The company has collaboration agreement with Gilead Sciences, Inc. for the development of filgotinib for inflammatory indications; and with Servier to develop GLPG1972. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium.
- [By Brian Feroldi, Chuck Saletta, and Todd Campbell]
But which biotech stocks are worth a closer look during this recent rally? We asked three Motley Fool contributors to weigh in, and they picked Galapagos (NASDAQ:GLPG), Celgene (NASDAQ:CELG), and Zealand Pharma (NASDAQ:ZEAL).
- [By Cory Renauer]
The end of the first quarter is just a few weeks away and more than a few biotechs still haven’t delivered the important clinical trial results they told investors to expect before the end of the period. The clock’s ticking for Axsome Therapeutics (NASDAQ:AXSM), Galapagos (NASDAQ:GLPG) and their experimental treatments.
- [By Ethan Ryder]
Cowen restated their buy rating on shares of GALAPAGOS NV/S (NASDAQ:GLPG) in a research report sent to investors on Friday morning.
Several other brokerages have also recently issued reports on GLPG. Zacks Investment Research raised shares of GALAPAGOS NV/S from a hold rating to a buy rating and set a $112.00 target price for the company in a report on Tuesday, October 30th. Raymond James started coverage on shares of GALAPAGOS NV/S in a report on Wednesday, November 14th. They issued a strong-buy rating and a $157.00 target price for the company. Credit Suisse Group decreased their target price on shares of GALAPAGOS NV/S from $92.00 to $90.00 and set a hold rating for the company in a report on Friday, October 26th. ValuEngine cut shares of GALAPAGOS NV/S from a strong-buy rating to a buy rating in a report on Wednesday, January 2nd. Finally, Nomura lifted their target price on shares of GALAPAGOS NV/S from $124.00 to $140.00 and gave the stock a buy rating in a report on Tuesday, October 30th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $123.64.
- [By Logan Wallace]
Get a free copy of the Zacks research report on GALAPAGOS NV/S (GLPG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com